1. An alternative approach for assessing drug induced seizures, using non-protected larval zebrafish
- Author
-
Pinion, Joseph, Tyler, Charles, Winter, Matthew, Goodfellow, Marc, and Randall, Andrew
- Subjects
Zebrafish ,Seizure ,Epilepsy ,Pharmacology ,PTZ ,Neuropharmacology ,Liability ,Drug Screening ,Local field potential recording ,Light sheet microscopy ,Behavioural ,Donepezil ,Picrotoxin ,Antidepressants ,Functional Connectivity ,Frequency Domain - Abstract
As many as 9% of epileptic seizures occur as a result of drug toxicity. Identifying compounds with seizurogenic side effects is imperative for assessing compound safety during drug development, however, multiple marketed drugs still have clinical associations with seizures. Moreover, current approaches for assessing seizurogenicity, namely rodent EEG and behavioural studies, are highly resource intensive. This being the case, alternative approaches have been postulated for assessing compound seizurogenicity, including in vitro, in vivo, and in silico methods. In this thesis, experimental work is presented supporting the use of larval zebrafish as a candidate model organism for developing new seizure liability screening approaches. Larval zebrafish are translucent, meaning they are highly amenable to imaging approaches while offering a more ethical alternative to mammalian research. Zebrafish are furthermore highly fecund facilitating capacity for both high replication and high throughput. The primary goal of this thesis was to identify biomarkers in larval zebrafish, both behavioural and physiological, of compounds that increase seizure liability. The efficacy of this model organism for seizure liability testing was assessed through exposure of larval zebrafish to a mechanistically diverse array of compounds, selected for their varying degrees of seizurogenicity. Their central nervous systems were monitored using a variety of different techniques including light sheet microscopy, local field potential recordings, and behavioural monitoring. Data acquired from these measurements were then analysed using a variety of techniques including frequency domain analysis, clustering, functional connectivity, regression, and graph theory. Much of this analysis was exploratory in nature and is reflective of the infancy of the field. Experimental findings suggest that larval zebrafish are indeed sensitive to a wide range of pharmacological mechanisms of action and that drug actions are reflected by behavioural and direct measurements of brain activity. For example, local field potential recordings revealed electrographic responses akin to pre-ictal, inter-ictal and ictal events identified in humans. Ca2+ imaging using light sheet microscopy found global increases in fluorescent intensity and functional connectivity due to seizurogenic drug administration. In addition, [2] further functional connectivity and graph analysis revealed macroscale network changes correlated with drug seizurogenicity and mechanism of action. Finally, analysis of swimming behaviour revealed a strong correlation between high speed swimming behaviours and administration of convulsant compounds. In conclusion, presented herein are data demonstrating the power of functional brain imaging, LFP recordings, and behavioral monitoring in larval zebrafish for assessing the action of neuroactive drugs in a highly relevant vertebrate model. These data help us to understand the relevance of the 4 dpf larval zebrafish for neuropharmacological studies and reveal that even at this early developmental stage, these animals are highly responsive to a wide range of neuroactive compounds across multiple primary mechanisms of action. This represents compelling evidence of the potential utility of larval zebrafish as a model organism for seizure liability testing.
- Published
- 2023